{
  "id": "everyday#screening_cues_e562193b",
  "title_en": "General — Screening Cues",
  "title_vi": "General — Dấu hiệu sàng lọc",
  "text_en": "252 Substance-Related and Addictive Disorders Unspecified Phencyclidine-Related Disorder 292.9 (F16.99) This category applies to presentations in which symptoms character- istic of a phencyclidine-related disorder that cause clinically signifi- cant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific phencyclidine-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class. Unspecified Hallucinogen-Related Disorder 292.9 (F16.99) This category applies to presentations in which symptoms character- istic of a hallucinogen-related disorder that cause clinically significant distress or impairment in social, occupational, or other important ar- eas of functioning predominate but do not meet the full criteria for any specific hallucinogen-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class. Inhalant-Related Disorders Inhalant Use Disorder A. A problematic pattern of use of a hydrocarbon-based inhalant substance leading to clinically significant impairment or distress, as manifested by at least two of the following, occurring within a 12-month period: 1. The inhalant substance is often taken in larger amounts or over a longer period than was intended. Inhalant Use Disorder 253 2. There is a persistent desire or unsuccessful efforts to cut down or control use of the inhalant substance. 3. A great deal of time is spent in activities necessary to obtain the inhalant substance, use it, or recover from its effects. 4. Craving, or a strong desire or urge to use the inhalant sub- stance. 5. Recurrent use of the inhalant substance resulting in a failure to fulfill major role obligations at work, school, or home. 6. Continued use",
  "gloss_vi": "252 substance-related and addictive disorders unspecified phencyclidine-related disorder 292.9 (f16.99) this category applies to presentations in which symptoms character- istic of a phencyclidine-related disorder that c...",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "screening_cues",
      "do_not_do"
    ],
    "life_topics": [
      "stress",
      "work"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Screening Cues General — Dấu hiệu sàng lọc 252 Substance-Related and Addictive Disorders Unspecified Phencyclidine-Related Disorder 292.9 (F16.99) This category applies to presentations in which symptoms character- istic of a phencyclidine-related disorder that cause clinically signifi- cant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific phencyclidine-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class. Unspecified Hallucinogen-Related Disorder 292.9 (F16.99) This category applies to presentations in which symptoms character- istic of a hallucinogen-related disorder that cause clinically significant distress or impairment in social, occupational, or other important ar- eas of functioning predominate but do not meet the full criteria for any specific hallucinogen-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class. Inhalant-Related Disorders Inhalant Use Disorder A. A problematic pattern of use of a hydrocarbon-based inhalant substance leading to clinically significant impairment or distress, as manifested by at least two of the following, occurring within a 12-month period: 1. The inhalant substance is often taken in larger amounts or over a longer period than was intended. Inhalant Use Disorder 253 2. There is a persistent desire or unsuccessful efforts to cut down or control use of the inhalant substance. 3. A great deal of time is spent in activities necessary to obtain the inhalant substance, use it, or recover from its effects. 4. Craving, or a strong desire or urge to use the inhalant sub- stance. 5. Recurrent use of the inhalant substance resulting in a failure to fulfill major role obligations at work, school, or home. 6. Continued use 252 substance-related and addictive disorders unspecified phencyclidine-related disorder 292.9 (f16.99) this category applies to presentations in which symptoms character- istic of a phencyclidine-related disorder that c..."
}